DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $489,253 | -0.9% | 1,972 | -4.1% | 0.15% | +5.5% |
| Q2 2023 | $493,680 | -5.6% | 2,057 | -0.8% | 0.14% | -10.5% |
| Q1 2023 | $522,731 | -4.5% | 2,074 | +0.6% | 0.16% | -6.9% |
| Q4 2022 | $547,296 | +1.5% | 2,062 | -1.2% | 0.17% | -9.4% |
| Q3 2022 | $539,051 | -5.4% | 2,087 | -7.1% | 0.19% | -1.0% |
| Q2 2022 | $569,659 | -13.6% | 2,247 | 0.0% | 0.19% | -5.8% |
| Q1 2022 | $659,113 | -10.8% | 2,247 | 0.0% | 0.21% | -10.8% |
| Q4 2021 | $739,285 | +6.6% | 2,247 | -1.4% | 0.23% | -4.9% |
| Q3 2021 | $693,819 | -7.2% | 2,279 | -18.2% | 0.24% | -11.6% |
| Q2 2021 | $747,919 | +14.7% | 2,787 | -3.8% | 0.28% | +5.0% |
| Q1 2021 | $652,282 | +1.4% | 2,898 | +0.1% | 0.26% | -8.4% |
| Q4 2020 | $643,095 | -19.3% | 2,895 | -21.8% | 0.29% | -29.7% |
| Q3 2020 | $796,936 | +17.9% | 3,701 | -3.1% | 0.41% | +11.5% |
| Q2 2020 | $675,667 | +22.8% | 3,821 | -3.9% | 0.36% | +4.6% |
| Q1 2020 | $550,318 | -21.7% | 3,976 | -13.2% | 0.35% | -8.9% |
| Q4 2019 | $703,245 | +1.4% | 4,582 | -4.6% | 0.38% | -7.5% |
| Q3 2019 | $693,408 | +0.2% | 4,801 | -0.9% | 0.41% | -4.2% |
| Q2 2019 | $692,162 | +8.3% | 4,843 | 0.0% | 0.43% | -3.6% |
| Q1 2019 | $639,373 | +22.9% | 4,843 | -4.0% | 0.45% | +11.7% |
| Q4 2018 | $520,034 | -6.9% | 5,043 | -1.9% | 0.40% | -0.2% |
| Q3 2018 | $558,838 | +2.6% | 5,143 | -6.8% | 0.40% | -1.2% |
| Q2 2018 | $544,418 | +0.8% | 5,517 | 0.0% | 0.41% | +1.2% |
| Q1 2018 | $540,169 | -1.5% | 5,517 | -6.6% | 0.40% | -1.0% |
| Q4 2017 | $548,566 | +7.3% | 5,910 | -0.8% | 0.41% | +5.5% |
| Q3 2017 | $511,249 | -8.2% | 5,960 | -9.7% | 0.38% | -12.9% |
| Q2 2017 | $557,143 | -5.3% | 6,602 | -4.0% | 0.44% | -5.8% |
| Q1 2017 | $588,275 | +9.8% | 6,878 | -0.1% | 0.47% | -6.2% |
| Q4 2016 | $536,006 | – | 6,886 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |